Abstract:Adenosine deaminase acting on RNA 2 (ADAR2) is an important enzyme involved in RNA editing processes, particularly in the conversion of adenosine to inosine in RNA molecules. Dysregulation of ADAR2 activity has been implicated in various diseases, including neurological disorders (including schizophrenia), inflammatory disorders, viral infections, and cancers. Therefore, targeting ADAR2 with small molecules presents a promising therapeutic strategy for modulating RNA editing and potentially treating associated pathologies. However, there are limited compounds that effectively inhibit ADAR2 reactions. This study therefore employed computational approaches to virtually screen natural compounds from the traditional Chinese medicine (TCM) library. The shortlisted compounds demonstrated a stronger binding affinity to the ADAR2 (<-9.5 kcal/mol) than the known inhibitor, 8-azanebularine (-6.8 kcal/mol). The topmost compounds were also observed to possess high binding affinity towards 5-HT2CR with binding energies ranging from -7.8 to -12.9 kcal/mol. Further subjecting the top ADAR2-ligand complexes to molecular dynamics simulations and molecular mechanics Poisson-Boltzmann surface area (MM/PBSA) calculations revealed that five potential hit compounds comprising ZINC000014637370, ZINC000085593577, ZINC000042890265, ZINC000039183320, and ZINC000101100339 had favorable binding free energies of -174.911, -137.369, -117.236, -67.023, and -64.913 kJ/mol, respectively, with the human ADAR2 protein. Residues Lys350, Cys377, Glu396, Cys451, Arg455, Ser486, Gln488, and Arg510 were also predicted to be crucial in ligand recognition and binding. This finding will provide valuable insights into the molecular interactions between ADAR2 and small molecules, aiding in the design of future ADAR2 inhibitors with potential therapeutic applications. The potential lead compounds were also profiled to have insignificant toxicities. A structural similarity search via DrugBank revealed that ZINC000039183320 and ZINC000014637370 were similar to naringin and naringenin, which are known adenosine deaminase (ADA) inhibitors. These potential novel ADAR2 inhibitors identified herein may be beneficial in treating several neurological disorders, cancers, viral infections, and inflammatory disorders caused by ADAR2 after experimental validation.

Design, Synthesis And Sar Studies Of Nad Analogues As Potent Inhibitors Towards Cd38 Nadase

Synthesis and Biological Evaluation of Nicotinamide Adenine Dinucleotides Analogues As Inhibitors of Cd38

Design, Synthesis and Biological Characterization of Novel Inhibitors of CD38.

Design, Synthesis and Biological Evaluation of Noncovalent Inhibitors of Human CD38 NADase

The Synthesis of Purine Derivatives and Its Inhibitory Activity on CD38 NADase

Studies on the Synthesis of Nicotinamide Nucleoside and Nucleotide Analogues and Their Inhibitions Towards CD38 NADase

Synthesis and Activity of Novel Indole Derivatives As Inhibitors of CD38

Catalysis-Based Inhibitors Of The Calcium Signaling Function Of Cd38

Rational Design and Identification of Small-Molecule Allosteric Inhibitors of CD38

One-pot Synthesis of Fluoro-Substituted Nicotinamide Nucleoside Phosphates

Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38

Synthesis of Novel Nicotinamide Adenine Dinucleotide (nad)analogs and Their Coenzyme Activities

Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D

Targeting Nad Biosynthesis in Bacterial Pathogens: Structure-Based Development of Inhibitors of Nicotinate Mononucleotide Adenylyltransferase Nadd

Synthesis, Biological, and Computational Evaluations of Conformationally Restricted NAD-Mimics as Discriminant Inhibitors of Human NMN-Adenylyltransferase Isozymes

Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents

Design, synthesis and structure-activity relationship of malonic acid non-nucleoside derivatives as potent CD73 inhibitors

In Silico Discovery of Potential Inhibitors Targeting the RNA Binding Loop of ADAR2 and 5-HT2CR from Traditional Chinese Natural Compounds

The Design, Synthesis, and Anti-Tumor Mechanism Study of N-phosphoryl Amino Acid Modified Resveratrol Analogues.

Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion

Design, Synthesis and Anti-Hiv Evaluation of Novel Diarylnicotinamide Derivatives (danas) Targeting the Entrance Channel of the NNRTI Binding Pocket Through Structure-Guided Molecular Hybridization